Bao-Ling Adam

发表

A low-cost, non-biologic, thoracentesis and thoracostomy simulator

James R. Yon, Caleb J. Mentzer, Bao-Ling Adam, 2014 .

Partially Supervised Learning Using an EM‐Boosting Algorithm

Li Hsu, Ziding Feng, Margaret S. Pepe, 2004, Biometrics.

A mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups

Yinglei Lai, Robert Podolsky, Bao-Ling Adam, 2007, Bioinform..

Computational protein biomarker prediction: a case study for prostate cancer

Alex Pothen, George L. Wright, Michael Wagner, 2004, BMC Bioinformatics.

Applying fuzzy ART in medical diagnosis of cancers

Jen-Ing G. Hwang, Lori Sokoll, Bao-Ling Adam, 2010, 2010 International Conference on Machine Learning and Cybernetics.

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.

Sudhir Srivastava, William E Grizzle, O John Semmes, 2004, Urologic oncology.

Serum Protein Profiles to Identify Head and Neck Cancer

O John Semmes, Bao-Ling Adam, Gunjan Malik, 2004, Clinical Cancer Research.

Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.

O John Semmes, Bao-Ling Adam, Lisa H Cazares, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers

O John Semmes, Daniel W Chan, Bao-Ling Adam, 2005, Proteomics.

Proteomic identification of serum biomarkers for head and neck cancer surveillance

Bao-Ling Adam, B. Adam, Christine G Gourin, 2009, The Laryngoscope.

Quality Control, Preparation, and Protein Stability Issues for Blood Serum and Plasma Used In Biomarker Discovery and Proteomic Profiling Assays

Lisa H. Cazares, O. John Semmes, Bao-Ling Adam, 2004 .

SELDI‐TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma

O John Semmes, Bao-Ling Adam, J. Marrero, 2005, Hepatology.

Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.

William E Grizzle, O John Semmes, Bao-Ling Adam, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bao-Ling Adam, Amina Ali, J. Moul, 2003, The Journal of urology.